What sector does DONGWHA PHARM.CO.,LTD belong to?

DONGWHA PHARM.CO.,LTD operates in the Pharmaceuticals sector, specifically the Pharmaceuticals industry, and is listed on the US markets.

What is the current share price of 000020?

As of the latest available quote, 000020 traded at ₩5,170.00. This price is delayed and cached for about 15 minutes.

What is the P/E ratio of 000020?

DONGWHA PHARM.CO.,LTD has a price-to-earnings (P/E) ratio of about 16.52. The P/E ratio compares the share price to earnings per share and is most useful when compared with sector peers and the company's own history.

What is the market capitalisation of 000020?

The market capitalisation of DONGWHA PHARM.CO.,LTD is approximately ₩63.47B.

Is DONGWHA PHARM.CO.,LTD profitable?

For its latest reported financial year, DONGWHA PHARM.CO.,LTD recorded a net profit margin of about 0.77%.

Does 000020 pay a dividend?

DONGWHA PHARM.CO.,LTD currently has a dividend yield of about 1.04%.

What is the return on equity (ROE) of 000020?

DONGWHA PHARM.CO.,LTD has a return on equity (ROE) of about 2.29%. ROE measures how much profit a company generates relative to shareholders' equity.

What is the 52-week high and low of 000020?

Over the past 52 weeks, 000020 has traded between a low of ₩4,450.00 and a high of ₩7,560.00.

DONGWHA PHARM.CO.,LTD

000020 KRX Pharmaceuticals Pharmaceuticals

KOSPI

₩5,170.00

+0.58%

Delayed · cached 15 min

Fair value analysis

000020

DONGWHA PHARM.CO.,LTD

₩5,170.00

Close used for this calculation

₩5,951.72Fair value

Financial DNA Score

Profitability · Returns · Balance Sheet · Efficiency · Growth

40/100

Profitability10/25

Returns12/25

Balance Sheet4/25

Efficiency14/25

Growth14/25

Average

Quality radar

Consensus fair value

₩5,951.72

Below FV

▲ +15.1% against the close used

Model range ₩685.54 – ₩9,788.52

The lowest and highest of the models that produced a value. This is the spread of the methods, not a price target.

Price target range & 52-week position

Bear₩685.54Fair value₩5,951.72Bull₩9,788.52

FairClose

52-week traded range

52W low ₩4,550.0052W high ₩6,670.00

The 52-week range is measured from the stored price history, not estimated.

Valuation summary

Trading below the consensus fair value

DONGWHA PHARM.CO.,LTD closed at ₩5,170.00, 13.1% below the consensus fair value of ₩5,951.72 drawn from 10 valuation models.

Financial DNA score 40/100 — Average. P/E of 16.5x against the 20x sector multiple the P/E model uses.

Quantitative summary only — not investment advice.

All valuation models

DCF Valuation

₩5,866.41

+13.5%

Σ[CF×(1+g)^n/(1.10)^n] + TV/(1.10)^10

g=8%, r=10%, tg=3%, n=10yr

Graham Number

₩9,788.52

+89.3%

√(22.5 × EPS × BVPS)

EPS=313, BVPS=13605.26

Graham Formula

₩3,547.33

-31.4%

EPS × (8.5 + 2g) × 4.4 ÷ FD_Rate

g=0%, FD=3.3%

P/E Fair Value

₩6,260.00

+21.1%

EPS × 20x (sector P/E)

EPS=313, Sector P/E=20x

Peter Lynch (PEG)

₩4,331.92

-16.2%

EPS × Growth% (PEG = 1 is fair)

EPS=313, g=13.8%

EV/EBITDA

₩6,689.12

+29.4%

(EBITDA × 10x − Net Debt) ÷ Shares

EBITDA=18.43B

Dividend Discount (DDM)

₩685.54

-86.7%

D1 ÷ (r − g) where D1 = D0×(1+g)

D0=53.77, r=10%, g=2%

Book Value (P/B)

₩3,115.61

-39.7%

BVPS × (ROE−g)÷(r−g) [Justified P/B — RIM-based]

BVPS=13605.26, ROE=2.3%, g=3%, r=10%

Reverse DCF

₩5,170.00

+0.0%

Solve for g: Price = Σ[EPS×(1+g)^n/(1.10)^n] + TV

Implied: 4.6% | Historical: -13.8%

Margin of Safety

₩4,774.17

-7.7%

Avg(DCF, Graham, P/E) × 75% (25% safety buffer)

Avg fair value=6365.57, MoS=25%

Computed on September 12, 2026 from the most recent annual report on file and that day's closing price. Where a company has seen its earnings move sharply since its last annual report, this figure will lag the market.

Educational data only. Not a recommendation to buy, sell or hold any security.

Fair value analysis

Consensus fair value

Price target range & 52-week position

Valuation summary

All valuation models

Equity Timer